Abnormalities of the cardiac stem and progenitor cell compartment in experimental and human diabetes

Anna Leonardini1, Angelo Avogaro

  • 1Department of Emergency and Organ Transplantation - Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro , Bari , Italy and.

Insights

Diabetic cardiomyopathy involves cardiac stem cell dysfunction. Preserving these cells may counteract diabetes-related heart damage, though cell therapy requires further research.

Area of Science:

  • Cardiovascular Biology
  • Stem Cell Biology
  • Metabolic Disease Research

Background:

  • Diabetic cardiomyopathy presents structural and functional cardiac changes.
  • Cardiac stem/progenitor cells (CSPC) are implicated in diabetic cardiomyopathy pathophysiology.
  • Diabetes negatively impacts CSPC number and function.

Purpose of the Study:

  • To review the role of CSPC in diabetic cardiomyopathy.
  • To explore how diabetes-induced factors affect CSPC.
  • To assess the potential of CSPC preservation and cell therapy.

Main Methods:

  • Literature review of recent studies on CSPC in diabetic hearts.
  • Analysis of the impact of hyperglycemia, hyperlipidemia, inflammation, and oxidative stress on CSPC.
  • Evaluation of the therapeutic potential of CSPC preservation and cell-based strategies.

Main Results:

  • Diabetic hearts show reduced numbers and impaired proliferation of CSPC.
  • Hyperglycemia, hyperlipidemia, inflammation, and oxidative stress contribute to CSPC defects.
  • An imbalance between CSPC death and replacement promotes diabetic cardiomyopathy progression.

Conclusions:

  • The CSPC compartment is crucial in diabetic cardiomyopathy.
  • Preserving CSPC may offer a strategy to mitigate diabetic cardiac damage.
  • Further research is needed to establish cell therapy as a clinical option.